In most respects, they are identical to listed
options on common stocks.
The Fund seeks to achieve the investment objective by investing primarily in: Dividend - paying common stocks, and by writing call
options on common stocks and common stock indices.
Not exact matches
HOUSTON, April 20, 2018 (GLOBE NEWSWIRE)-- Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) a clinical stage biopharmaceutical company focused
on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders, today announced the closing of its previously announced underwritten public offering of 9,200,000 shares of its
common stock, including 1,200,000 shares sold pursuant to the underwriters» full exercise of their
option to purchase additional shares, at a public offering price of $ 7.50 per share.
It is now quite
common, should a
stock collapse, for companies to lower the purchase price
on options already granted to employees, in order to stem a mass exodus of talent.
Based
on the number of shares outstanding as of December 31, 2010, upon the completion of this offering, shares of Class A
common stock and 88,955,943 shares of Class B
common stock will be outstanding, assuming no exercise of the underwriters» over-allotment
option and no exercise of outstanding
options.
From January 1, 2008 through December 31, 2010, the Registrant granted to its employees, consultants and other service providers
options to purchase an aggregate of 12,566,833 shares of
common stock under the Registrant's Amended and Restated 2003 Stock Incentive Plan, or the 2003 Plan, at exercise prices ranging from $ 1.50 to $ 14.46 per share, which includes options to purchase shares of common stock that were repriced on a one - for - one basis to $ 2.32 per share in February
stock under the Registrant's Amended and Restated 2003
Stock Incentive Plan, or the 2003 Plan, at exercise prices ranging from $ 1.50 to $ 14.46 per share, which includes options to purchase shares of common stock that were repriced on a one - for - one basis to $ 2.32 per share in February
Stock Incentive Plan, or the 2003 Plan, at exercise prices ranging from $ 1.50 to $ 14.46 per share, which includes
options to purchase shares of
common stock that were repriced on a one - for - one basis to $ 2.32 per share in February
stock that were repriced
on a one - for - one basis to $ 2.32 per share in February 2009.
From January 1, 2008 through December 31, 2010, the Registrant granted to certain executive officers, directors and other investors
options and rights to purchase an aggregate of 8,196,662 shares of
common stock under the 2003 Plan at exercise prices ranging from $ 2.00 to $ 6.20 per share, which includes
options to purchase shares of
common stock that were repriced
on a one - for - one basis to $ 2.32 per share in February 2009.
«Total CEO realized compensation» for a given year is defined as (i) Mr. Musk's salary, cash bonuses, non-equity incentive plan compensation and all other compensation as reported in «Executive Compensation — Summary Compensation Table» below, plus (ii) with respect to any
stock option exercised by Mr. Musk in such year in connection with which shares of
stock were also sold other than to satisfy the resulting tax liability, if any, the difference between the market price of Tesla
common stock at the time of exercise
on the exercise date and the exercise price of the
option, plus (iii) with respect to any restricted
stock unit vested by Mr. Musk in such year in connection with which shares of
stock were also sold other than automatic sales to satisfy the Company's withholding obligations related to the vesting of such restricted
stock unit, if any, the market price of Tesla
common stock at the time of vesting, plus (iv) any cash actually received by Mr. Musk in respect of any shares sold to cover tax liabilities as described in (ii) and (iii) above, following the payment of such amounts.
On Sept. 30, 2017, there were 52,268,443 shares of
common stock issued and outstanding, and
stock options to purchase 7,685,449 shares of
common stock issued and outstanding.
The Compensation Committee believes that
options to purchase shares of our
common stock, with an exercise price equal to the market price of our
common stock on the date of grant, are inherently performance - based and are a very effective tool to motivate our executives to build stockholder value and reinforce our position as a growth company.
for serving as the lead independent director, (i)
on the later of June 12, 2012 or shortly following appointment as the lead independent director, and (ii) every three years thereafter, an automatic grant of a
stock option to purchase 24,000 shares of our
common stock;
Routinely, companies rely
on common structures for
stock option plans and build in little innovation and creativity.
We provide information below about (1) the circumstances under which these
options and
stock awards vest upon termination of employment or the occurrence of certain acquisitions, and (2) the hypothetical value each such named executive would have received, if any, upon the vesting of any of these
option or
stock awards as of that date under those circumstances, assuming each named executive's employment with the Company had terminated or the acquisition had been consummated as of December 31, 2009 and based
on an NYSE closing price per share of our
common stock on that date of $ 26.99.
On July 9, 2015, Mr. Johnson was granted an
option to purchase 38,000 shares of our
common stock, which he early exercised for restricted shares of our
common stock that were subject to the same vesting schedule as the
option.
The Deferred Compensation Plan, which allows eligible team members to defer salary, bonuses and certain other compensation and earn an investment return
on the deferred compensation based
on, among other earnings
options,
common stock share equivalents distributed in shares of
common stock.
On June 9, 2011, Dr. Summers was granted an
option to purchase 1,288,000 shares of our
common stock, which he early exercised for restricted shares of our
common stock that were subject to the same vesting schedule as the
option.
2,816,100 shares of our Class A
common stock issuable upon the exercise of
options to purchase shares of our Class A
common stock granted after September 30, 2015 under our 2015 Equity Incentive Plan, with an exercise price per share equal to the public offering price set forth
on the cover page of the final prospectus for this offering;
The plan offers a number of earnings
options, including one based
on our
common stock with dividends reinvested.
As of March 31, 2014, we had outstanding
options to purchase an aggregate of LLC Units that are exchangeable
on a one - for - one basis for shares of our Class A
common stock and LLC Units issuable upon the vesting of RSUs that are exchangeable
on a one - for - one basis for shares of our Class A
common stock issuable upon the vesting of RSUs.
The 2004 Plan permits the grant of the following types of Awards: (1) nonstatutory
stock options, incentive
stock options and
stock appreciation rights granted at the fair market value of our
common stock on the date of grant (Fair Market Value Awards), and (2) restricted
stock awards and restricted
stock units (Full Value Awards).
If the shares of
common stock are sold or otherwise disposed of before the end of the one - year and two - year periods specified above, the difference between the
option exercise price and the fair market value of the shares
on the date of the
options» exercise will
We provide information below about (1) the circumstances under which the vesting of these
options and
stock awards would accelerate upon termination of employment or the consummation of an «acquisition transaction» (as defined below) and (2) the hypothetical value each such named executive would have received, if any, upon the vesting of any of these
option or
stock awards as of that date under those circumstances, assuming each named executive's employment with the Company had terminated or the acquisition had been consummated as of December 31, 2011 and based
on an NYSE closing price per share of our
common stock of $ 27.56
on December 30, 2011, the last trading date in 2011.
in the case of our directors, officers, and security holders, (i) the receipt by the locked - up party from us of shares of Class A
common stock or Class B
common stock upon (A) the exercise or settlement of
stock options or RSUs granted under a
stock incentive plan or other equity award plan described in this prospectus or (B) the exercise of warrants outstanding and which are described in this prospectus, or (ii) the transfer of shares of Class A
common stock, Class B
common stock, or any securities convertible into Class A
common stock or Class B
common stock upon a vesting or settlement event of our securities or upon the exercise of
options or warrants to purchase our securities
on a «cashless» or «net exercise» basis to the extent permitted by the instruments representing such
options or warrants (and any transfer to us necessary to generate such amount of cash needed for the payment of taxes, including estimated taxes, due as a result of such vesting or exercise whether by means of a «net settlement» or otherwise) so long as such «cashless exercise» or «net exercise» is effected solely by the surrender of outstanding
stock options or warrants (or the Class A
common stock or Class B
common stock issuable upon the exercise thereof) to us and our cancellation of all or a portion thereof to pay the exercise price or withholding tax and remittance obligations, provided that in the case of (i), the shares received upon such exercise or settlement are subject to the restrictions set forth above, and provided further that in the case of (ii), any filings under Section 16 (a) of the Exchange Act, or any other public filing or disclosure of such transfer by or
on behalf of the locked - up party, shall clearly indicate in the footnotes thereto that such transfer of shares or securities was solely to us pursuant to the circumstances described in this bullet point;
The table above does not include (i) 5,952,917 shares of Class A
common stock reserved for issuance under our 2015 Incentive Award Plan (as described in «Executive Compensation — New Employment Agreements and Incentive Plans»), consisting of (x) 2,689,486 shares of Class A
common stock issuable upon exercise of
options to purchase shares of Class A
common stock granted
on the date of this prospectus to our directors and certain employees, including the named executive officers, in connection with this offering as described in «Executive Compensation — Director Compensation» and «Executive Compensation — New Equity Awards,» and (y) 3,263,431 additional shares of Class A
common stock reserved for future issuance and (ii) 24,269,792 shares of Class A
common stock issuable to the Continuing SSE Equity Owners upon redemption or exchange of their LLC Interests as described in «Certain Relationships and Related Party Transactions — SSE Holdings LLC Agreement.»
Provided, however, that an incentive
stock option held by a participant who owns more than 10 % of the total combined voting power of all classes of our
stock, or of certain of our parent or subsidiary corporations, may not have a term in excess of five years and must have an exercise price of at least 110 % of the fair market value of our
common stock on the grant date.
nonstatutory
stock options may not be less than 85 % of the fair market value of our
common stock on the date of grant.
The number of shares of our Class A
common stock outstanding after this offering as shown in the tables above is based
on the number of shares outstanding as of September 24, 2014, after giving effect to the Transactions and the Assumed Redemption, and excludes 5,952,917 shares of Class A
common stock reserved for issuance under our 2015 Incentive Award Plan (as described in «Executive Compensation — New Employment Agreements and Incentive Plans»), consisting of (i) 2,689,486 shares of Class A
common stock issuable upon the exercise of
options to purchase shares of Class A
common stock granted
on the date of this prospectus to our directors and certain employees, including the named executive officers, in connection with this offering as described in «Executive Compensation --
Based
on shares outstanding as of December 31, 2016,
on the closing of this offering, we will have outstanding a total of shares of Class A
common stock, shares of Class B
common stock, and shares of Class C
common stock, assuming no exercise of outstanding
options, and after giving effect to the conversion of all outstanding shares of our preferred
stock into shares of Class B
common stock on the closing of this offering and the sale of Class A
common stock by the selling stockholders in this offering.
All
stock options and
stock appreciation rights will have an exercise price equal to at least the fair market value of our
common stock on the date the
stock option or
stock appreciation right is granted, except in certain situations in which we are assuming or replacing
options granted by another company that we are acquiring.
The number of shares of our Class A
common stock outstanding after this offering as shown in the tables above is based
on the number of shares outstanding as of September 24, 2014, after giving effect to the Transactions and the Assumed Redemption, and excludes shares of Class A
common stock reserved for issuance under our 2015 Incentive Award Plan (as described in «Executive Compensation — New Employment Agreements and Incentive Plans»), consisting of (i) shares of Class A
common stock issuable upon the exercise of
options to purchase shares of Class A
common stock granted
on the date of this prospectus to our directors and certain employees, including the named executive officers, in connection with this offering as described
Each non-employee director who, as of the date of this offering, is serving
on our board of directors and is expected to continue his or her service following this offering will be granted an
option to purchase shares of our Class A
common stock with a grant date fair value of $ 50,000 (or, if such director is unaffiliated with any significant stockholder of the Company, $ 75,000)
on the date the shares subject to this offering are priced.
On the date the shares subject to this offering are priced, each non-employee director who, as of the date of this offering, is serving on our board of directors and is expected to continue his or her service following this offering will be granted (a) an option to purchase shares of our Class A common stock with a grant date fair value of $ 50,000 (or, if such director is unaffiliated with any significant stockholder of the Company, $ 75,000) and (b) to the extent such director is (i) unaffiliated with any significant stockholder of the Company and (ii) the chairman of any committee of our board of directors, an additional option to purchase shares of our Class A common stock with a fair value of $ 10,000 with respect to each such chairmanshi
On the date the shares subject to this offering are priced, each non-employee director who, as of the date of this offering, is serving
on our board of directors and is expected to continue his or her service following this offering will be granted (a) an option to purchase shares of our Class A common stock with a grant date fair value of $ 50,000 (or, if such director is unaffiliated with any significant stockholder of the Company, $ 75,000) and (b) to the extent such director is (i) unaffiliated with any significant stockholder of the Company and (ii) the chairman of any committee of our board of directors, an additional option to purchase shares of our Class A common stock with a fair value of $ 10,000 with respect to each such chairmanshi
on our board of directors and is expected to continue his or her service following this offering will be granted (a) an
option to purchase shares of our Class A
common stock with a grant date fair value of $ 50,000 (or, if such director is unaffiliated with any significant stockholder of the Company, $ 75,000) and (b) to the extent such director is (i) unaffiliated with any significant stockholder of the Company and (ii) the chairman of any committee of our board of directors, an additional
option to purchase shares of our Class A
common stock with a fair value of $ 10,000 with respect to each such chairmanship.
We intend to file one or more registration statements
on Form S - 8 under the Securities Act to register all shares of Class A
common stock (i) subject to outstanding
stock options granted in connection with this offering, (ii) issued or issuable under our
stock plans and (iii) issued to the Former UAR Plan Participants.
Under the ESPP, participants are offered the
option to purchase shares of our
common stock at a discount during a series of successive offering periods, which will normally commence
on and of each year.
Based
on the valuation of our
common stock completed in March 2012, the fair value of RSUs and exercise price of
stock options granted through October 12, 2012 was determined to be $ 14.42 per share.
The exercise price of
stock options granted under our equity incentive plans is equal to the fair market value of FedEx's
common stock on the date of grant.
We have based our calculation of the number of shares outstanding after the offering and the percentage of beneficial ownership after the offering
on shares of our
common stock outstanding immediately after the completion of this offering, including shares that we estimate will be issued pursuant to the 2014 Recapitalization assuming an initial public offering price of $ per share (the midpoint of the price range
on the cover of this prospectus), and no exercise of the underwriters» overallotment
option to purchase shares from the selling stockholders.
Nonstatutory
Stock Options, or NSOs, will provide for the right to purchase shares of our common stock at a specified price, which may not be less than fair market value on the date of grant, and usually will become exercisable (at the discretion of the administrator) in one or more installments after the grant date, subject to the participant's continued employment or service with us and / or subject to the satisfaction of corporate performance targets and individual performance targets established by the administr
Stock Options, or NSOs, will provide for the right to purchase shares of our
common stock at a specified price, which may not be less than fair market value on the date of grant, and usually will become exercisable (at the discretion of the administrator) in one or more installments after the grant date, subject to the participant's continued employment or service with us and / or subject to the satisfaction of corporate performance targets and individual performance targets established by the administr
stock at a specified price, which may not be less than fair market value
on the date of grant, and usually will become exercisable (at the discretion of the administrator) in one or more installments after the grant date, subject to the participant's continued employment or service with us and / or subject to the satisfaction of corporate performance targets and individual performance targets established by the administrator.
As of September 30, 2014, we had outstanding
options to purchase an aggregate of LLC Units that are exchangeable
on a one - for - one basis for shares of our Class A
common stock and LLC Units issuable upon the vesting of RSUs that are exchangeable
on a one - for - one basis for shares of our Class A
common stock issuable upon the vesting of RSUs.
The exercise price of
options granted under our 2013 Plan must at least be equal to the fair market value of our
common stock on the date of grant.
The exercise price of
options granted under our 2014 Plan must at least be equal to the fair market value of our Class A
common stock on the date of grant.
We provide information below about (1) the circumstances under which the vesting of these
options and
stock awards would accelerate upon termination of employment or the consummation of an «acquisition transaction» (as defined below) and (2) the hypothetical value each such named executive would have received, if any, upon the vesting of any of these
option or
stock awards as of that date under those circumstances, assuming each named executive's employment with the Company had terminated or the acquisition had been consummated as of December 31, 2010 and based
on an NYSE closing price per share of our
common stock on that date of $ 30.99.
Since the portfolio
options are unlimited, I decided to focus
on «the market» and two very
common stock / bond ratios.
Each of the
stock options is exercisable for a five year term expiring
on March 6, 2023 at a price of $ 0.37 per
common share.
Regardless of the reported value of a
stock option on the grant date, the actual value realized will depend
on the excess, if any, of the market value of the Company's
common stock over the exercise price if and when the
option is exercised.
Given his financial experience, Mr. Paulson had to know how deceptive his promise was in placing such emphasis
on the government's
stock options, the sweetener that has made so many executives fabulously wealthy: «taxpayers will not only own shares that should be paid back with a reasonable return, but also will receive warrants for
common shares in participating institutions,» he explained.
Choose this
option to be shown the most
common Cookbook trim sizes and paper
stock options on the following screens.
Choose this
option to be shown the most
common Children's book trim sizes and paper
stock options on the following screens.
Choose this
option to be shown the most
common Yearbook trim sizes and paper
stock options on the following screens.
Choose this
option to be shown the most
common Academic, Textbook, and Journal trim sizes and paper
stock options on the following screens.